Zepbound vs Rybelsus: Full Comparison (2026)
How does Zepbound (Tirzepatide) compare to Rybelsus (Semaglutide (oral))? We break down the weight loss data, pricing, side effects, and who each medication is best suited for.
Zepbound (Tirzepatide, Dual GLP-1/GIP receptor agonist) and Rybelsus (Semaglutide (oral), GLP-1 receptor agonist) work through different mechanisms. Zepbound is FDA-approved for chronic weight management with 20-22% of body weight average weight loss at $1,060/mo. Rybelsus is approved for type 2 diabetes with 5-10% of body weight average weight loss at $936/mo.
Side-by-Side Comparison
| Feature | Zepbound | Rybelsus |
|---|---|---|
| Active Ingredient | Tirzepatide | Semaglutide (oral) |
| Mechanism | Dual GLP-1/GIP receptor agonist | GLP-1 receptor agonist |
| FDA Approved For | Chronic weight management | Type 2 diabetes |
| Doses | 2.5mg to 15mg (weekly injection) | 3mg, 7mg, 14mg (daily oral tablet) |
| Administration | Weekly subcutaneous injection | Daily oral tablet on empty stomach |
| Avg. Weight Loss | 20-22% of body weight | 5-10% of body weight |
| Monthly Price | $1,060 | $936 |
| Oral Available | No | Yes |
| Year Approved | 2023 | 2019 |
Prices reflect typical self-pay costs without insurance. Actual costs vary by pharmacy, location, and insurance plan. Last updated March 2026.
Which Produces More Weight Loss?
Based on clinical data, Zepbound produces more weight loss on average (20-22% of body weight) compared to Rybelsus (5-10% of body weight). Zepbound uses Tirzepatide (Dual GLP-1/GIP receptor agonist), while Rybelsus uses Semaglutide (oral) (GLP-1 receptor agonist), which may account for the difference.
FDA-approved for chronic weight management. Same active ingredient as Mounjaro (tirzepatide). Shows the highest average weight loss of any currently approved GLP-1 medication.
First oral GLP-1 medication. Lower doses than injectable semaglutide, resulting in less weight loss. Convenient for patients who prefer pills over injections.
Which Costs Less?
At list price, Rybelsus is the more affordable option at $936/month compared to $1,060/month for Zepbound. However, actual out-of-pocket costs depend heavily on your insurance plan. Zepbound with insurance: Varies by plan. Rybelsus with insurance: $10-$150/month typical copay.
LillyDirect program for eligible patients
Manufacturer savings programs available
Side Effects Comparison
Both Zepbound (Dual GLP-1/GIP receptor agonist) and Rybelsus (GLP-1 receptor agonist) share similar gastrointestinal side effects, which are the most commonly reported:
- Nausea (most common for both medications)
- Diarrhea and vomiting
- Constipation
- Abdominal pain
- Decreased appetite
- Headache, fatigue, dizziness (less common)
Serious but rare side effects for both include pancreatitis, gallbladder problems, and kidney issues. Both carry warnings about medullary thyroid carcinoma risk based on animal studies. Always discuss your full medical history with your doctor before starting either medication.
Which Should You Choose?
The best choice depends on your diagnosis, insurance coverage, weight loss goals, and personal preferences. Here is our general guidance:
- -Your primary goal is weight loss (FDA-approved indication)
- -You want the dual GLP-1/GIP mechanism for potentially greater efficacy
- -You prefer the convenience of once-weekly dosing
- -You have type 2 diabetes (on-label use, better insurance coverage)
- -You prefer an oral option over injections
- -Cost is a concern ($936/month at list price)
- -You prefer a daily dosing routine
Find the Best GLP-1 Provider for You
Compare verified telehealth programs that prescribe Zepbound, Rybelsus, and other FDA-approved GLP-1 medications.
Frequently Asked Questions
Can I switch from Zepbound to Rybelsus?
Switching between Zepbound and Rybelsus is possible but requires medical supervision since they contain different active ingredients (Tirzepatide vs Semaglutide (oral)). Your doctor will determine the appropriate starting dose and titration schedule for the new medication.
Which is better for weight loss: Zepbound or Rybelsus?
Clinical data suggests Zepbound produces more weight loss on average (20-22% of body weight) compared to Rybelsus (5-10% of body weight). However, individual results vary significantly based on dosing, diet, exercise, and metabolic factors.
Is Zepbound cheaper than Rybelsus?
At list price, Rybelsus ($936/month) is less expensive than Zepbound ($1,060/month). With insurance, costs vary significantly. Zepbound: Varies by plan. Rybelsus: $10-$150/month typical copay.
Do Zepbound and Rybelsus have the same side effects?
Both medications share similar gastrointestinal side effects (nausea, diarrhea, vomiting, constipation) as these are common to GLP-1 receptor agonists. However, since they contain different active ingredients, there may be differences in frequency and severity. Discuss your medical history with your doctor to determine which has a better safety profile for you.
Does insurance cover Zepbound and Rybelsus?
Coverage varies by plan. Zepbound is FDA-approved for chronic weight management — insurance coverage is typically better for on-label use. Rybelsus is FDA-approved for type 2 diabetes. Check with your specific insurance plan and ask your doctor about prior authorization requirements.